Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lapaquistat with High Dose Statin in Primary Hypercholesterolemia
NCT00249899Phase 3Terminated
- Sponsor
- Takeda
- Start
- Nov 2005
- Primary completion
- Mar 2007
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 3 trial of lapaquistat in hypercholesterolemia, sponsored by Takeda. Started Nov 2005; status: terminated.
02
Drugs
lapaquistat
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on NCT00249899.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00249899.